ABN AMRO Bank N.V. Raises Position in Xylem Inc. $XYL

ABN AMRO Bank N.V. grew its position in shares of Xylem Inc. (NYSE:XYL) by 2.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,637,096 shares of the industrial products company’s stock after buying an additional 36,992 shares during the quarter. Xylem accounts for 2.4% of ABN AMRO Bank N.V.’s portfolio, making the stock its 13th largest position. ABN AMRO Bank N.V. owned about 0.67% of Xylem worth $240,511,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. SJS Investment Consulting Inc. boosted its stake in Xylem by 1,844.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company’s stock valued at $26,000 after purchasing an additional 166 shares during the last quarter. First Horizon Corp purchased a new position in shares of Xylem in the third quarter worth $30,000. Grey Fox Wealth Advisors LLC bought a new position in shares of Xylem during the third quarter valued at $34,000. Caldwell Trust Co purchased a new stake in shares of Xylem during the second quarter valued at $41,000. Finally, FWL Investment Management LLC bought a new stake in Xylem in the 2nd quarter worth about $43,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Wall Street Zen cut shares of Xylem from a “buy” rating to a “hold” rating in a research note on Saturday, December 27th. Barclays dropped their target price on shares of Xylem from $172.00 to $166.00 and set an “overweight” rating on the stock in a report on Wednesday, January 7th. Stifel Nicolaus boosted their target price on shares of Xylem from $175.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Weiss Ratings restated a “buy (b-)” rating on shares of Xylem in a research note on Monday, December 29th. Finally, Argus set a $170.00 price objective on Xylem in a report on Wednesday, October 29th. Nine investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, Xylem currently has a consensus rating of “Moderate Buy” and an average target price of $165.80.

Xylem Price Performance

Shares of Xylem stock opened at $139.71 on Thursday. The stock has a market cap of $34.02 billion, a P/E ratio of 35.92, a P/E/G ratio of 1.97 and a beta of 1.17. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.50 and a current ratio of 1.96. The stock’s fifty day moving average is $139.47 and its 200 day moving average is $141.98. Xylem Inc. has a one year low of $100.47 and a one year high of $154.27.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th were paid a dividend of $0.40 per share. The ex-dividend date was Tuesday, November 25th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem’s payout ratio is 41.13%.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.